Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 9 de 9
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
Intervalo de ano de publicação
1.
Saudi J Biol Sci ; 29(6): 103274, 2022 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-35345871

RESUMO

Recent worldwide outbreak of SARS-COV-2 pandemic has increased the thirst to discover and introduce antiviral drugs to combat it. The bioactive compounds from plant sources, especially terpenoid have protease inhibition activities so these may be much effective for the control of viral epidemics and may reduce the burden on health care system worldwide. Present study aims the use of terpenoid from selected plant source through bioinformatics tools for the inhibition of SARS-COV-2. This study is based on descriptive analysis. The Protein Data Bank and PubChem database were used for the analysis of SARS-COV-2 protease and plant source terpenoids. Molecular docking by using molegro virtual docker (MVD) software was carried out. The findings of study are based on the inhibitory actions of different plant sourced terpenoid against SARS-COV-2. As per the available resources and complementary analysis these phytochemicals have capacity to inhibit 3CLpro protease. The study reports that (3,3-dimethylally) isoflavone (Glycine max), licoleafol (Glycyrrhiza uralensis), myricitrin (Myrica cerifera), thymoquinone (Nigella sativa), bilobalide, ginkgolide A (Ginkgo biloba), Salvinorin A (Salvia divinorum), citral (Backhousia citriodora) and prephenazine (drug) showed high activity against SARS-COV-2 protease 3CLpro. The drug like and ADMET properties revealed that these compounds can safely be used as drugs. Cross structural analysis by using bioinformatics study concludes that these plant source terpenoid compounds can be effectively used as antiprotease drugs for SARS-COV-2 in future.

2.
Pak J Pharm Sci ; 31(4(Supplementary)): 1495-1499, 2018 Jul.
Artigo em Inglês | MEDLINE | ID: mdl-30058541

RESUMO

Bacterial infection is one of the vital sources of morbidity and mortality. The development of single photon emission computed tomography (SPECT) radiotracer agents using antibiotics, for targeting in-vivo bacteria, helps in antibiotic dose calibration, targeted infection therapy and reduction in mortality rate. The aim of this study was to appraised 99mTc-labeling sulfadiazine as a radiopharmaceutical for bacillus infections imaging. Radiolabeling of sulfadiazine with technetium-99m was carried out by subsequent addition of 1.5 mL aqueous solution of sulfadiazine (1mg/mL), 120µg stannous tartrate, gentistic acid as stabilizing agent and 185 MBq normal saline solution of 99mTcO4-1 (pertechnetate) at pH = 5. The reaction mixture was incubated for 40 min at room temperature with light stirring. The quality control analysis (ITLC-SG and paper chromatography analysis) revealed ~ 98% labeling yield. Biodistribution and scintigraphic study was carried using bacillus bacterial infection induced New Zealand white rabbits. Due to the ease of 99mTc-sulfadiazine conjugation method, high labeling efficiency, shelf stability (>95% up to 6h), blood serum stability (~90% up to 6h) and high uptake in the infected muscle (T/NT =2.21 at 1H), 99mTc-SDZ could be used as radiopharmaceutical of choice for further pre-clinical and clinical studies.


Assuntos
Antibacterianos/metabolismo , Bacillus , Modelos Animais de Doenças , Infecções por Bactérias Gram-Positivas/metabolismo , Sulfadiazina/metabolismo , Tecnécio/metabolismo , Animais , Antibacterianos/uso terapêutico , Bacillus/isolamento & purificação , Avaliação Pré-Clínica de Medicamentos/métodos , Infecções por Bactérias Gram-Positivas/diagnóstico por imagem , Infecções por Bactérias Gram-Positivas/tratamento farmacológico , Humanos , Masculino , Tomografia por Emissão de Pósitrons/métodos , Coelhos , Sulfadiazina/uso terapêutico , Tecnécio/administração & dosagem , Distribuição Tecidual/efeitos dos fármacos , Distribuição Tecidual/fisiologia , Tomografia Computadorizada de Emissão de Fóton Único/métodos
3.
Environ Sci Pollut Res Int ; 25(12): 11884-11892, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29446025

RESUMO

Bisphenol A (BPA) is a widely used environmental pollutant in the production of plastics but causes hepatotoxicity in mammals. In the present study, we studied the BPA-induced oxidative stress in rats and ameliorative potential of Adiantum capillus-veneris L. plant. It was concluded that the BPA can reduce the body and liver weight, increase in biochemical levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST), total bilirubin, and disturb the normal hepatic physiology, histology, and metabolism. Additionally, liver histology shows hepatic necrosis, congestion, and vacuolization in exposed individuals. In contrast, simultaneous exposure of A. capillus-veneris and BPA showed declining trend in serum biomarker levels and normal histopathological structures. We conclude that the A. capillus-veneris plant is antioxidant in nature and can reduce the BPA-induced toxicity. These findings are very helpful to understand the BPA-induced hepatic toxicity and ameliorative potential of A. capillus-veneris plant and are of great importance in risk assessment of xenobiotics.


Assuntos
Adiantum/química , Compostos Benzidrílicos/antagonistas & inibidores , Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Poluentes Ambientais/antagonistas & inibidores , Fígado/efeitos dos fármacos , Fenóis/antagonistas & inibidores , Extratos Vegetais/uso terapêutico , Animais , Antioxidantes/uso terapêutico , Compostos Benzidrílicos/toxicidade , Poluentes Ambientais/toxicidade , Masculino , Fenóis/toxicidade , Ratos , Ratos Wistar
4.
Pak J Pharm Sci ; 30(6(Supplementary)): 2383-2387, 2017 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-29188773

RESUMO

Hepatitis C is the most common health problem worldwide and is major cause of death due to proliferation of hepatocellular carcinoma. The medicines available for HCV treatment overcome up-to 95% complications of HCV. However, liver cancer needs some additional care. Normally Sorafenib tosylate 200 mg is recommended for liver cancer. There is no such trial in which this drug could effectively be used in combination of direct acting antivirals for HCV. The study was conducted for HCV patients (n=30) with liver cancer having decompensated stage. Combination of Sorafenib tosylate, Ribavirn and Sofosbuvir were used for the pharmacokinetics of these medicines. Child pugh score less then 7 (CP A) in adults during treatment phase (received 12 weeks of Sorafenib tosylate 200 mg, Ribavirn and Sofosbuvir 400 mg once daily) have no side effect while child pugh score 7-9 (CP B) have evidence of hypertension. The main efficiency end point sustained virology response with overcoming liver cancer as well in 12 weeks after end treatment (SVR-LLC 12). Mean pharmacokinetic exposure to Sorafenib tosylate 200 mg, Ribavirn and Sofosbuvir at week 8th was 2.1, 1.5,1.2 times greater in CP B than in CP A. Adverse effects (AEs) were observed in 12 out of 30 patients but not severe as lethal for life. Treatment with Sorafenib tosylate, Ribavirn and Sofosbuvir for twelve weeks was harmless and well accepted, 100 % patients achieve (SVR LLC 12) with 10-fold cure rate more than previous ones. The combination therapy of Sorafenib tosylate, Ribavirn and Sofosbuvir was found helpful for the management of decompensated liver cancer.


Assuntos
Carcinoma Hepatocelular/tratamento farmacológico , Hepatite C/tratamento farmacológico , Neoplasias Hepáticas/tratamento farmacológico , Ribavirina/uso terapêutico , Sofosbuvir/uso terapêutico , Sorafenibe/uso terapêutico , Adulto , Idoso , Carcinoma Hepatocelular/diagnóstico , Carcinoma Hepatocelular/virologia , Quimioterapia Combinada , Feminino , Hepatite C/diagnóstico , Hepatite C/virologia , Humanos , Neoplasias Hepáticas/diagnóstico , Neoplasias Hepáticas/virologia , Masculino , Pessoa de Meia-Idade , Ribavirina/efeitos adversos , Ribavirina/farmacocinética , Sofosbuvir/efeitos adversos , Sofosbuvir/farmacocinética , Sorafenibe/efeitos adversos , Sorafenibe/farmacocinética , Resposta Viral Sustentada , Resultado do Tratamento
5.
Environ Sci Pollut Res Int ; 23(12): 11645-57, 2016 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-26936479

RESUMO

The current study presents the bisphenol A exposure and the ameliorative effects of Adiantum capillus-veneris on testicular toxicity induced by bisphenol A. Adult male albino rats were divided into five groups of five animals each: A (control), B (vehicle control), C (toxic), D (protective), and E (ameliorative) were served distilled water, olive oil, bisphenol A (BPA) at 100 mg/kg body weight, A. capillus-veneris plant extract at 25 mg/kg body weight, and BPA + A. capillus-veneris, respectively. All of the doses were administered orally for 15 days, and the rats were then sacrificed. Blood samples for the testosterone assay and both testes were collected for histological examination. The body weight, paired testes weight, relative tissue weight index, Johnsen scoring of tubules, and level of serum testosterone decreased in BPA-treated rats. Similarly, histological examination of the testes in BPA-treated animals revealed a lower number of Leydig cells, an irregular basement membrane, sloughing of germinal layers, vacuolization, a lower number of spermatocytes, and debris in the lumen. However, co-administration of A. capillus-veneris with BPA increased the total antioxidative capacity (330.82 ± 22.46 µmol/mg protein) of the testes and restored the serum testosterone level (1.70 ng/ml); histological features showed restoration in the stages of spermatogenesis. Conclusively, A. capillus-veneris plant extract overcomes the estrogenic effects of BPA on the reproductive system of rats and protects rats' testes against BPA-induced injury/damage via an antioxidative mechanism that appears to be conciliated.


Assuntos
Adiantum , Antioxidantes/uso terapêutico , Compostos Benzidrílicos/toxicidade , Estrogênios não Esteroides/toxicidade , Fenóis/toxicidade , Extratos Vegetais/uso terapêutico , Reprodução/efeitos dos fármacos , Animais , Antioxidantes/farmacologia , Disruptores Endócrinos/toxicidade , Masculino , Tamanho do Órgão/efeitos dos fármacos , Extratos Vegetais/farmacologia , Ratos , Testículo/efeitos dos fármacos , Testículo/patologia , Testosterona/sangue
6.
Molecules ; 20(11): 20487-98, 2015 Nov 18.
Artigo em Inglês | MEDLINE | ID: mdl-26593893

RESUMO

Eucalyptus is well reputed for its use as medicinal plant around the globe. The present study was planned to evaluate chemical composition, antimicrobial and antioxidant activity of the essential oils (EOs) extracted from seven Eucalyptus species frequently found in South East Asia (Pakistan). EOs from Eucalyptus citriodora, Eucalyptus melanophloia, Eucalyptus crebra, Eucalyptus tereticornis, Eucalyptus globulus, Eucalyptus camaldulensis and Eucalyptus microtheca were extracted from leaves through hydrodistillation. The chemical composition of the EOs was determined through GC-MS-FID analysis. The study revealed presence of 31 compounds in E. citriodora and E. melanophloia, 27 compounds in E. crebra, 24 compounds in E. tereticornis, 10 compounds in E. globulus, 13 compounds in E. camaldulensis and 12 compounds in E. microtheca. 1,8-Cineole (56.5%), α-pinene (31.4%), citrinyl acetate (13.3%), eugenol (11.8%) and terpenene-4-ol (10.2%) were the highest principal components in these EOs. E. citriodora exhibited the highest antimicrobial activity against the five microbial species tested (Staphylococcus aureus, Bacillus subtilis, Escherichia coli, Aspergillus niger and Rhizopus solani). Gram positive bacteria were found more sensitive than Gram negative bacteria to all EOs. The diphenyl-1-picrylhydazyl (DPPH) radical scavenging activity and percentage inhibition of linoleic acid oxidation were highest in E. citriodora (82.1% and 83.8%, respectively) followed by E. camaldulensis (81.9% and 83.3%, respectively). The great variation in chemical composition of EOs from Eucalyptus, highlight its potential for medicinal and nutraceutical applications.


Assuntos
Anti-Infecciosos/química , Antioxidantes/química , Eucalyptus/química , Óleos Voláteis/química , Extratos Vegetais/química , Antibacterianos/química , Antibacterianos/farmacologia , Anti-Infecciosos/farmacologia , Antioxidantes/farmacologia , Cromatografia Gasosa-Espectrometria de Massas , Testes de Sensibilidade Microbiana , Óleos Voláteis/farmacologia , Extratos Vegetais/farmacologia
7.
J Ayub Med Coll Abbottabad ; 27(2): 346-50, 2015.
Artigo em Inglês | MEDLINE | ID: mdl-26411113

RESUMO

BACKGROUND: Isoniazid (INH) is the drug of choice for treatment of tuberculosis (TB) and it is a well-known-cause of acute clinical liver injury which can be severe and sometimes fatal. The study was designed to investigate the effects of Saccharum officinarum L. juice on oxidative liver injury due to INH in mice. METHODS: This was a laboratory based experimental study. Thirty mice were divided into three groups, containing 10 mice each. Group A being the control, group B and C were experimental and were treated orally with INH 100 mg/kg per day and INH 100 mg/kg per day plus Saccharum officinarum L. juice 15 ml/ kg per day respectively for a period of 30 days. Blood samples were taken at 30th day by cardiac puncture under anaesthesia and liver in each was taken out for microscopic examination. RESULTS: INH treated mice showed; rise in serum ALT, AST, ALP and total bilirubin levels (Mean?SEM), while group C mice treated with Saccharum officinarum L. juice significantly decreased the levels of these biochemical parameters. The histopathological examination of groups A showed normal liver structure which was deranged in (INH) group B, whereas group C showed significant recovery in histological structure. Saccharum officinarum L. constituents, especially flavanoids and anthocyanins have strong antioxidant properties which provides hepatoprotection against oxidative liver injury produced by INH. CONCLUSION: INH-induced liver injury is associated with oxidative stress, and co-administration of Saccharum officinarum L. juice (15 ml/Kg bw) may reduce this damage effectively in mice.


Assuntos
Doença Hepática Induzida por Substâncias e Drogas/tratamento farmacológico , Fígado/efeitos dos fármacos , Fitoterapia/métodos , Preparações de Plantas/farmacologia , Saccharum , Animais , Doença Hepática Induzida por Substâncias e Drogas/metabolismo , Modelos Animais de Doenças , Isoniazida/toxicidade , Fígado/metabolismo , Masculino , Camundongos , Estresse Oxidativo
8.
J Ayub Med Coll Abbottabad ; 23(4): 53-7, 2011.
Artigo em Inglês | MEDLINE | ID: mdl-23472413

RESUMO

BACKGROUND: Use of gentamicin is now limited due to its toxic effects, mainly on kidney and vestibular system. Herbal products including ginseng has been reported to possess protective effects against drugs induced nephrotoxicity in experimental animals. The current investigation was designed to evaluate the effects of ginseng on gentamicin induced nephrotoxicity. METHODS: Eighteen male albino mice of 6-8 weeks age, were divided into 3 groups. Group-A served as control and was given normal mouse diet; Group-B was given 80 mg/Kg/day of gentamicin intraperitoneally dissolved in 1 ml of distilled water for fifteen days. Group-C was given 80 mg/Kg/day of gentamicin intraperitoneally dissolved in 1 ml of distilled water along with 100 mg/Kg/day of ginseng orally dissolved in 1 ml of distilled water, also for fifteen days. At the end of the experiment, blood was drawn from each animal by cardiac puncture for renal function tests. Each animal was then sacrificed and kidneys removed for routine histological studies. RESULTS: In group B, weight of the animals and kidneys decreased and there was significant increase in mean serum urea, creatinine and intraluminal diameter (p < 0.001) of proximal convoluted tubules as compared to the controls (group-A). Moderate to severe necrotic and degenerative changes in proximal convoluted tubules were seen in this group. When the Ginseng and gentamicin were given together (group-C), a statistically significant improvement in the mean body and kidney weight along with improvement in renal function tests and tubular diameter were seen (p < 0.001). CONCLUSION: It appears that Ginseng has some protective role against gentamicin induced nephrotoxicity.


Assuntos
Gentamicinas/toxicidade , Nefropatias/induzido quimicamente , Nefropatias/tratamento farmacológico , Panax , Análise de Variância , Animais , Testes de Função Renal , Masculino , Camundongos , Tamanho do Órgão , Distribuição Aleatória
9.
J Ayub Med Coll Abbottabad ; 21(1): 148-51, 2009.
Artigo em Inglês | MEDLINE | ID: mdl-20364766

RESUMO

BACKGROUND: The therapeutic value of Eugenia jambolana, commonly known as 'Jamun' in Hindi, has been recognized in different system of traditional medicine for the treatment of various conditions. Its seeds are used for the treatment of diabetes mellitus and hyperlipedemia by reducing the lipid levels in the body; this action is presumed to be due to blocking the action of enzyme 3-hydroxyl methyl glutaryl (HMG-CoA reductase in the liver. Herbal drugs are getting into use with the notion that these are relatively harmless; the practice has shown that many of them also have toxic effects. Since hardly any work is available on the toxic aspect of Eugenia Jamblana, the present study was planed to see the effect-of ethanolic extract of Eugenia Jamblana on liver using albino rats as an experimental model. METHODS: The animals were divided into three groups A, B and C. Group A served as a control and received only distilled water comparable to the experimental animals calculated according to their body weight, where as B and C served as experimental groups. 100 and 200 mg of ethanolic extract of Eugenia Jamblana was dissolved in one ml of distilled water each and was given orally for 30 days/kg body weight. RESULTS: liver enzyme ALT and gamma GT were significantly raised when compared to the control group, p-value being < 0.05. Histological studies showed ballooning degeneration of hepatocytes, focal areas of hepatocytes necrosis with lymphocytic infiltration, providing supportive evidence for biochemical findings indicative of functional derangement. The effect of the extract was not dose dependent. Statistical analysis using ANOVA and chi-square showed statistically significant difference when the values from experimental animals were compared with those from the control, indicating that the ethanolic extract of Eugenia Jamblana seed possesses hepatotoxic effect. CONCLUSION: The ethanolic extract of Eugenia jambolana seed extract is toxic to liver as evident by derangement in liver enzyme levels and disturbed liver histology.


Assuntos
Hepatócitos/efeitos dos fármacos , Fígado/efeitos dos fármacos , Extratos Vegetais/toxicidade , Sementes/toxicidade , Syzygium/toxicidade , Alanina Transaminase/sangue , Análise de Variância , Animais , Hepatócitos/patologia , Fígado/enzimologia , Fígado/patologia , Masculino , Extratos Vegetais/efeitos adversos , Extratos Vegetais/uso terapêutico , Distribuição Aleatória , Ratos , Sementes/efeitos adversos , Syzygium/efeitos adversos , gama-Glutamiltransferase/sangue
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA